Ceruvia Lifesciences, a leading neurotransformational medicine biopharmaceutical company today announced the submission of an IND application to begin a Phase 1, single center, randomized,...
MyOme, a clinical whole genome platform analysis company, announced that the company has raised $23 million in an oversubscribed series B financing round led...
G42 Healthcare, an Abu Dhabi-based leading health tech company and subsidiary of G42, an artificial intelligence and cloud computing company located in Abu Dhabi...
Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced it has received approval by the Bellberry Human Research Ethics Committee (HREC) in Australia to initiate...
BlueAllele Corporation, a biotechnology company focused on advancing transformational gene correction technologies, announced that the United States Patent and Trademark Office (USPTO) has issued...
